MBX
MBX Biosciences, Inc.Company with tickers: MBX
Market Cap
$2.30B
Shares Outstanding
47,597,536
CIK
1776111
CUSIP
55287L101
13F Activity (30d)
3 filings
2 filers
Website
Visit website
Investor Relations
Investor relations
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Edward T. Mathers | Class II Director | Appointed | 2026-06-05 |
| Patrick J. Heron | Class II Director | Appointed | 2026-06-05 |